Centanafadine
- Generic Name
- Centanafadine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H15N
- CAS Number
- 924012-43-1
- Unique Ingredient Identifier
- D2A6T4UH9C
- Background
Centanafadine is under investigation in clinical trial NCT02827513 (A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects).
- Associated Conditions
- -
- Associated Therapies
- -
Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder
- Conditions
- Interventions
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2024-10-24
- Target Recruit Count
- 336
- Registration Number
- NCT05536414
- Locations
- ๐บ๐ธ
For additional information regarding sites, contact 844-687-8522, Austin, Texas, United States
A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder
- First Posted Date
- 2021-11-09
- Last Posted Date
- 2023-09-01
- Target Recruit Count
- 147
- Registration Number
- NCT05113953
- Locations
- ๐บ๐ธ
iResearch Atlanta, Decatur, Georgia, United States
๐บ๐ธPsych Atlanta, PC, Marietta, Georgia, United States
๐บ๐ธPrinceton Medical Institute, Princeton, New Jersey, United States
Efficacy of Centanafadine SR as a Potential Smoking Cessation Treatment
- First Posted Date
- 2021-10-04
- Last Posted Date
- 2023-06-13
- Target Recruit Count
- 50
- Registration Number
- NCT05066724
- Locations
- ๐บ๐ธ
Rose Research Center, Raleigh, North Carolina, United States
A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
- First Posted Date
- 2021-03-08
- Last Posted Date
- 2023-07-13
- Target Recruit Count
- 50
- Registration Number
- NCT04786730
- Locations
- ๐บ๐ธ
For additional information regarding sites, contact 844-687-8522, San Antonio, Texas, United States
A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine in Pediatric Subjects With Attention-deficit/Hyperactivity Disorder
- First Posted Date
- 2020-05-21
- Last Posted Date
- 2022-06-02
- Target Recruit Count
- 32
- Registration Number
- NCT04398225
- Locations
- ๐บ๐ธ
For additional information regarding sites, contact 844-687-8522, Hollywood, Florida, United States
Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD)
- First Posted Date
- 2019-09-09
- Last Posted Date
- 2023-01-13
- Target Recruit Count
- 13
- Registration Number
- NCT04081363
- Locations
- ๐บ๐ธ
For additional information regarding sites, contact 844-687-8522, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.